Regional differences in chronic neuroleptic effects on extracellular dopamine activity

Area of Science:

• Neuroscience
• Pharmacology
• Neurochemistry

Background:

• Long-acting injectable antipsychotics like haloperidol and fluphenazine decanoate are crucial for managing chronic psychiatric conditions.
• Understanding their long-term effects on dopamine pathways is essential for optimizing treatment strategies.

Purpose of the Study:

• To investigate the persistent effects of chronic haloperidol and fluphenazine decanoate administration on extracellular dopamine and its metabolites.
• To compare the impact of these neuroleptics on the nigrostriatal and mesolimbic dopamine pathways.

Main Methods:

• Intracranial microdialysis was used to measure extracellular dopamine (DA) and metabolite levels in the caudate-putamen (CPu) and nucleus accumbens (NA) of rats.
• Neuroleptic levels were assessed in plasma, and brain responses to amphetamine and nomifensine were evaluated.

Main Results:

• Chronic haloperidol (HAL) and fluphenazine (FLU) decanoate treatments resulted in sustained plasma neuroleptic levels.
• FLU treatment elevated homovanillic acid (HVA) in the CPu, while HAL treatment elevated 3,4-dihydroxyphenylacetic acid (DOPAC) in the CPu.
• Neuroleptic-treated rats showed an enhanced response to dopamine-releasing agents in the CPu, indicating increased extracellular DA activity.

Conclusions:

• Chronic administration of haloperidol and fluphenazine decanoate leads to enhanced extracellular dopamine activity specifically within the nigrostriatal pathway.
• The mesolimbic dopamine pathway appears less affected by long-term treatment with these neuroleptics.
• These findings suggest differential long-term neurochemical adaptations in distinct dopamine systems following antipsychotic therapy.